CellWell record HH-417503
Clinical utility of lipoprotein(a) and the ApoB/ApoA-I ratio in the risk assessment of acute coronary syndrome: from single biomarkers to integrated risk stratification
Zuqiang Lu; Pankui Li; Ruirui Li; Xiangqian Guo; Shuangshuang Li; Jing Wang
2026
In plain language
This narrative review synthesizes evidence that lipoprotein(a) and the ApoB/ApoA-I ratio are linked to coronary lesion severity, plaque instability, and prognosis in acute coronary syndrome.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-417503
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.